Malik MS - Search Results

1

Antibacterial Properties and Computational Insights of Potent Novel Linezolid-Based Oxazolidinones.

Malik MS, Faazil S, Alsharif MA, Sajid Jamal QM, Al-Fahemi JH, Banerjee A, Chattopadhyay A, Pal SK, Kamal A, Ahmed SA. Malik MS, et al. Pharmaceuticals (Basel). 2023 Mar 30;16(4):516. doi: 10.3390/ph16040516. Pharmaceuticals (Basel). 2023. PMID: 37111273 Free PMC article.

2

Efforts towards the development of new antitubercular agents: potential for thiolactomycin based compounds.

Kamal A, Azeeza S, Malik MS, Shaik AA, Rao MV. Kamal A, et al. Among authors: malik ms. J Pharm Pharm Sci. 2008 Sep 9;11(2):56s-80s. doi: 10.18433/j36k5k. J Pharm Pharm Sci. 2008. PMID: 19203471 Free article. Review.

3

Search for new and novel chemotherapeutics for the treatment of human malignancies.

Kamal A, Azeeza S, Bharathi EV, Malik MS, Shetti RV. Kamal A, et al. Among authors: malik ms. Mini Rev Med Chem. 2010 May;10(5):405-35. doi: 10.2174/138955710791330918. Mini Rev Med Chem. 2010. PMID: 20370699 Review.

4

Optimization of nitrilase production from Alcaligenes faecalis MTCC 10757 (IICT-A3): effect of inducers on substrate specificity.

Nageshwar YV, Sheelu G, Shambhu RR, Muluka H, Mehdi N, Malik MS, Kamal A. Nageshwar YV, et al. Among authors: malik ms. Bioprocess Biosyst Eng. 2011 Jun;34(5):515-23. doi: 10.1007/s00449-010-0500-0. Epub 2010 Dec 25. Bioprocess Biosyst Eng. 2011. PMID: 21188422

5

Apoptosis-inducing agents: a patent review (2010 - 2013).

Kamal A, Faazil S, Malik MS. Kamal A, et al. Among authors: malik ms. Expert Opin Ther Pat. 2014 Mar;24(3):339-54. doi: 10.1517/13543776.2014.877445. Epub 2014 Jan 10. Expert Opin Ther Pat. 2014. PMID: 24405450 Review.

6

Recent developments towards podophyllotoxin congeners as potential apoptosis inducers.

Kamal A, Hussaini SM, Malik MS. Kamal A, et al. Among authors: malik ms. Anticancer Agents Med Chem. 2015;15(5):565-74. doi: 10.2174/1871520614666141130125623. Anticancer Agents Med Chem. 2015. PMID: 25469512 Review.

7

Embracing synthetic lethality of novel anticancer therapies.

Kamal A, Shaik TB, Malik MS. Kamal A, et al. Among authors: malik ms. Expert Opin Drug Discov. 2015 Oct;10(10):1119-32. doi: 10.1517/17460441.2015.1072167. Epub 2015 Jul 27. Expert Opin Drug Discov. 2015. PMID: 26211783 Review.

8

Design and synthesis of cis-restricted benzimidazole and benzothiazole mimics of combretastatin A-4 as antimitotic agents with apoptosis inducing ability.

Ashraf M, Shaik TB, Malik MS, Syed R, Mallipeddi PL, Vardhan MVPSV, Kamal A. Ashraf M, et al. Among authors: malik ms. Bioorg Med Chem Lett. 2016 Sep 15;26(18):4527-4535. doi: 10.1016/j.bmcl.2016.06.044. Epub 2016 Jun 17. Bioorg Med Chem Lett. 2016. PMID: 27515320

9

Rational design and synthesis of 2-anilinopyridinyl-benzothiazole Schiff bases as antimitotic agents.

Shaik TB, Hussaini SMA, Nayak VL, Sucharitha ML, Malik MS, Kamal A. Shaik TB, et al. Among authors: malik ms. Bioorg Med Chem Lett. 2017 Jun 1;27(11):2549-2558. doi: 10.1016/j.bmcl.2017.03.089. Epub 2017 Mar 30. Bioorg Med Chem Lett. 2017. PMID: 28400235

10

Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents.

Seddigi ZS, Malik MS, Saraswati AP, Ahmed SA, Babalghith AO, Lamfon HA, Kamal A. Seddigi ZS, et al. Among authors: malik ms. Medchemcomm. 2017 Jul 4;8(8):1592-1603. doi: 10.1039/c7md00227k. eCollection 2017 Aug 1. Medchemcomm. 2017. PMID: 30108870 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page